Total investments received (USD): 1.14m
Round value (USD): 1.14m
Round investors:
UZH Life Sciences Fund
Company: FimmCyte





Belgium
Netherlands
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
United Kingdom